ClinicalTrials.Veeva

Menu

Blood Pressure Assessment in Atrial Fibrillation

N

National and Kapodistrian University of Athens

Status

Unknown

Conditions

Atrial Fibrillation

Study type

Observational

Funder types

Other

Identifiers

NCT01088269
BPM IN AF

Details and patient eligibility

About

This is a cross-sectional study including patients with permanent atrial fibrillation. Assessment will include:

  • clinic blood pressure measurements (mercury sphygmomanometer and automated oscillometric device)
  • 24-hour ambulatory blood pressure monitoring
  • determination of various serum markers and cardiac ultrasound.
  • evaluation of a 24h ambulatory blood pressure monitoring device (Microlife WatchBPO3) in terms of its diagnostic value for the detection of atrial fibrillation compared with the reference 24h Holter ECG

Enrollment

100 estimated patients

Sex

All

Ages

25 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hypertensives adults in atrial fibrillation

Exclusion criteria

  • Renal disease (Cr > 2 mg/l).
  • Patients with pacemaker rhythm during the study.
  • Each patient with acute disease (inflammation, surgery), malignancy, collagen diseases, pulmonary fibrosis, renal failure, liver failure, chronic inflammatory diseases.

Trial design

100 participants in 2 patient groups

AF
Description:
Hypertensive patients in AF
Non-AF
Description:
Hypertensive Patients

Trial contacts and locations

1

Loading...

Central trial contact

George S Stergiou, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems